The South African Health Products Regulatory Authority (SAHPRA) released a guideline outlining insurance requirements for interventional clinical trials involving human participants, aimed at ensuring participant protection and Regulatory clarity during clinical trial approvals.
Key Highlights:
- Policy Focus:
- Establishes clear insurance requirements for clinical trials involving human participants to ensure adequate risk coverage.
- Scope:
- Applicable to all interventional clinical trials submitted to SAHPRA for approval.
- Key Requirements / Provisions:
- Mandatory Insurance Coverage: Insurance is required for all interventional clinical trials involving human participants.
- Participant Protection: Sponsors/applicants are expected to provide compensation for trial-related injuries, including death, even in the absence of legal liability.
- Informed Consent Transparency: Informed consent documents must clearly outline procedures for reporting trial-related harm and details on compensation and treatment.
- Insurance Certificate Submission: A valid insurance certificate with specified details must be submitted as part of the clinical trial application.
- Claims Process Clarity: Defined procedures for handling and processing compensation claims related to trial injuries.
- Regulatory Updates:
- Administrative update clarifying insurance requirements for clinical trial approvals (effective March 27, 2026).
- Regulatory Goals:
- Strengthen participant safety and ethical standards in clinical trials.
- Ensure consistent and transparent insurance practices across sponsors and applicants.
Select Mandate HA
Select Mandate Function